<DOC>
	<DOCNO>NCT00445081</DOCNO>
	<brief_summary>To investigate comparative efficacy Ciclosporine A Prednisolone adult patient severe atopic dermatitis .</brief_summary>
	<brief_title>Prednisolone vs. Ciclosporine Severe Atopic Eczema</brief_title>
	<detailed_description />
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>male female patient age &gt; = 18 &lt; 55 weight 50 100 kg confirm diagnosis AE ( UK work party criterion ) objective SCORAD &gt; 40 DLQI &gt; 10 resistancy topical treatment option include steroid calcineurininhibitors participation another clinical trial within last 4 week baseline pregnant breastfeed woman childbearing potential without adequate contraception allergy prednisolone Ciclosporine A acute bacterial viral infection malignant tumor personal history diabetes mellitus arterial hypertension Glaucoma peptic ulcer severe osteoporosis tuberculosis personal history colitis ulcerosa diverticulitis concurrent treatment chloroquin , Mefloquin , Statins , Warafin Creatinin Clearance &lt; 60 ml /min UV treatment within 8 week inclusion ongoing systemic immunosuppressive treatment plan vaccination within 8 week study entry , study 2 week end study Poliomyelitis Lymphadenitis BCG vaccination Hyperuricaemia chronic liver disease Xeroderma pigmentosum , CockayeSyndrome , Bloom Syndrome Psychiatric comorbidity drug alcohol abuse</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>atopic dermatitis</keyword>
	<keyword>prednisolone</keyword>
	<keyword>ciclosporine</keyword>
	<keyword>SCORAD</keyword>
	<keyword>DLQI</keyword>
	<keyword>QALY</keyword>
	<keyword>WLQ</keyword>
</DOC>